Stereotactic Surgery Devices Market Regional Analysis:
North American Market Insights
Stereotactic surgery devices market in North America is predicted to account for the largest share of 42% by 2035 impelled by the rising government initiative to increase cancer awareness. Recently 50 new actions and commitments to end cancer were announced by the President of the United States to decrease the cancer death rate and to prevent more than 3 million cancer deaths by 2047. For instance, The American Cancer Society (ACS) will develop a new curriculum and certification program for oncology professional navigators to support individuals with cancer which is an essential component in clinical settings to improve cancer outcomes in the United States, by ensuring that every cancer patient obtains timely, high-quality, and culturally competent care.
APAC Market Statistics Insights
The APAC stereotactic surgery devices market is estimated to be the second largest, during the forecast timeframe led by growing medical tourism. India has evolved as a medical tourism hotspot that provides patients from all over the world with affordable, high-quality healthcare services. Moreover, India was ranked 10th in the 2020-2021 Medical Tourism Index, and its reputation as a top destination for medical treatments is projected to rise in the future years. This can lead to an increase in the demand for stereotactic surgery devices in the region.
For instance, more than 1 million patients from over 75 countries visit India each year for medical, wellness, and IVF treatments, generating roughly USD 5 billion for the business, which is predicted to grow to around USD 12 billion by 2026.
